Abstract: Apparatus and methods of the present invention utilize sensed acoustical energy and may detect both instability of an ablation electrode during the ablation process and/or crater formation during tissue ablation.
Abstract: Cardiac pacing systems are disclosed for providing multi-site pacing in a single heart chamber or multi-chamber pacing in two or more heart chambers employing N pacing channels and miniaturized electrical isolation circuitry in up to N−1 pacing channels to minimize the effects of leakage currents generated during delivery of a pacing pulse in any one pacing channel from affecting sense amplifiers in the other pacing channels. Isolation of a the pace/sense electrodes from leakage currents is effected employing monolithic isolation circuit means. An isolated current replicator employing giant magnetoresistive (GMR) sense elements in conjunction with isolated planar cells fabricated in monolithic form is incorporated into conventional VLSI circuitry. Or, the monolithic isolation circuit means is formed of a micro-mechanical fabricated (MEMS) isolation transformer comprising low-loss input and output coils separated by an insulation layer that isolates the input coil from the output coil.
Abstract: Epilepsy and other neurological disorders that are affected by the electrical potential difference between intracellular fluid and extra-cellular fluid and therefore the cell membrane potentials, and therefore the thresholds for the communication between brain cells can be controlled by re-circulating extra-cellular brain fluid after the fluid has been treated to alter its ion concentrations. A computer-controlled pump can precisely control the extraction and delivery of brain fluid after the ion concentration of the fluid is appropriately adjusted, e.g. guided by the Goldmann equation. Well-known techniques for modifying ion concentrations can be used to raise or lower ion concentrations as needed.
Type:
Grant
Filed:
June 18, 2002
Date of Patent:
March 23, 2004
Assignee:
Medtronic, Inc.
Inventors:
Johan F. M. Gijsbers, Frans L. H. Gielen
Abstract: Polymers that include silane-containing groups in soft segments, and optionally urethane groups, as well as medical devices and methods for making such compounds.
Type:
Application
Filed:
September 16, 2003
Publication date:
March 18, 2004
Applicant:
Medtronic, Inc.
Inventors:
Michael E. Benz, Christopher M. Hobot, Kelvin Bonnema, Randall V. Sparer
Abstract: Compounds that include diorgano groups having quaternary carbons, silicon-containing groups, and optionally urethane groups, urea groups, or combinations thereof (i.e., polyurethanes, polyureas, or polyurethane-ureas), as well as materials and methods for making such compounds.
Type:
Application
Filed:
September 16, 2003
Publication date:
March 18, 2004
Applicant:
Medtronic, Inc.
Inventors:
Michael E. Benz, Christopher M. Hobot, Randall V. Sparer
Abstract: An apparatus and method for producing composite data by a server computer with a distributed communication controller interface involves deforming a template creating a mapping relationship between co-registered data and subject data, filtering the co-registered data, and mapping this filtered co-registered data according to the mapping data. A client computer with a distributed communication controller interface requests the composite data from the server computer and transmits the subject data to the server computer. The client presents the received composite data to an operator and monitors the operators use of the composite data.
Abstract: A guidewire apparatus for use during percutaneous catheter interventions such as angioplasty or stent deployment. A protection element comprising a filter or an occluder is mounted near the distal end of a steerable guidewire, which guides a therapeutic catheter. The guidewire apparatus comprises a hollow shaft movably disposed about a core wire. The shaft and core wire control relative displacement of the ends of the protection element, causing transformation of the protection element between a deployed configuration and a collapsed configuration. The protection element is freely rotatable about the guidewire apparatus. A tracking member disposed adjacent the distal end of the guidewire apparatus can be used to guide the device along another guidewire. Thrust bearings may be employed to facilitate unlimited rotation of the steerable guidewire within the protection element, especially while the protection element is retained in the collapsed configuration.
Type:
Grant
Filed:
January 24, 2003
Date of Patent:
March 16, 2004
Assignee:
Medtronic Ave Inc.
Inventors:
Nareak Douk, Nasser Rafiee, David J. Sauvageau, Steve Dapolito
Abstract: In one embodiment, a testing regimen is implemented to reduce test time. Specifically, a structure and method to power up and stabilize all die on the wafer prior to testing each die is implemented. More specifically, parallel powering schemes including die stabilization procedures are used to ready the wafer for testing. A wafer probe tester is indexed from one die to the next for an uninterrupted testing of all die in the wafer subsequent to all die power up and stabilization.
Abstract: A device for monitoring temperature generated by an ablation apparatus on organic tissue is provided. The device comprises a temperature sensing pad; and an output device to receive and display a representation of a lesion found on the ablated organic tissue. Ablation systems incorporating the device and methods of using the device are also provided.
Type:
Grant
Filed:
April 9, 2003
Date of Patent:
March 16, 2004
Assignee:
Medtronic, Inc.
Inventors:
David E. Francischelli, Scott E. Jahns, James R. Keogh
Abstract: Methods for improving detection of arrhythmias by adaptively increasing arrhythmia detection intervals. One method includes increasing the V2V, the overall cardiac cycle length, thereby decreasing the pacing rate in the presence of ventricular safety paces (VSPs). Another method includes shortening the trigger interval following the atrial pace event, during which time the pacemaker will detect V-sense events, while leaving the A2V VSP interval unchanged, at the end of which any required VSP will be generated. In yet another method, the interval from A-pace to V-pace, the PAV interval, is shortened, while leaving the overall V2V cycle interval unchanged. This increases the ventricular to artial V2A interval, increasing the detection window for arthythmias. The PAV interval can be shortened in response to a recent history of VSP events.
Type:
Grant
Filed:
October 30, 2001
Date of Patent:
March 16, 2004
Assignee:
Medtronic, Inc.
Inventors:
James H. Ericksen, Martin A. Rossing, Fareed Assad
Abstract: An improved connection system for coupling a device such as a pacemaker, cardioverter, defibrillator, nerve stimulator, muscle stimulator, implantable monitor or other medical device to a medical lead is disclosed. The connection system includes a coupling member designed to couple to the proximal end of the lead. This coupling member, which includes an inner lumen sized to form a press fit around the proximal end of the lead body, may be of a generally tubular construction. This coupling member includes connector means to enable a connector pin at the proximal end of the lead to mechanically and electrically couple to a device. The connector means may further include means for coupling both mechanically and electrically to a ring connector on the proximal end of a multi-polar lead. An insertion member may also be provided to allow the lead to be more easily inserted within the inner lumen of the coupling member.
Type:
Grant
Filed:
April 19, 2001
Date of Patent:
March 16, 2004
Assignee:
Medtronic, Inc.
Inventors:
John L. Sommer, Douglas S. Hine, Vicki L. Bjorklund, Elisabeth Lacy Belden, William J. Clemens, Andrew J. Ries, Jordon D. Honeck, Harry Schroder
Abstract: A method and apparatus for creating a virtual electrode to ablate bodily tissue. The apparatus includes an outer tube, a first electrode, an inner tube and a second electrode. The outer tube is fluidly connected to a source of conductive fluid and defines a proximal end and a distal end. The distal end includes an opening for delivering conductive fluid from the outer tube. The first electrode is disposed at the distal end of the outer tube for applying a current to conductive fluid delivered from the outer tube. The inner tube is coaxially received within the outer tube and is connected to a source of conductive fluid. The inner tube defines a proximal end and a distal end, with the distal end forming an opening for delivering conductive fluid from the inner tube. Finally, the second electrode is disposed at the distal end of the inner tube for applying a current to conductive fluid delivered from the inner tube.
Abstract: A catheter assembly for treatment of cardiac arrhythmia. The catheter assembly includes a catheter body and an ablative energy source. The catheter body includes a proximal portion, an intermediate portion, and a distal portion. The intermediate portion extends from the proximal portion and defines a longitudinal axis. The distal portion extends from the intermediate portion and includes an ablation section and a tip. The ablation section forms a loop defining a diameter greater than an outer dimension of a pulmonary vein ostium. The tip extends distally from the ablation section and is configured to locate a pulmonary vein. Finally, the ablative energy source is associated with the ablation section. With this configuration, upon activation of the energy source, the ablation section ablates a desired lesion pattern. In one preferred embodiment, the ablation section forms a distally decreasing radius helix, whereas the tip includes a relatively linear leader section.
Abstract: An implantable medical device with a main processor also has a telemetry processor to perform some telemetry processing functions resulting under some circumstances in reducing demands on the main processor, conserving energy, increasing telemetry processing speed, and many other advantages. A wide variety of implantable medical devices can be configured with a telemetry processor including neuro stimulators, pacemakers, defibrillators, drug delivery pumps, diagnostic recorders, and cochlear implants. The telemetry processor includes control logic, a data decoder, a receive buffer, a data encoder, and a transmit buffer. Methods of receiving messages and transmitting messages with a telemetry processor are also disclosed.
Type:
Application
Filed:
September 5, 2003
Publication date:
March 11, 2004
Applicant:
Medtronic, Inc.
Inventors:
Allen Dale Almendinger, Martinus A. G. M. Bakx
Abstract: The present invention provides active agent delivery systems for use in medical devices, wherein the active agent delivery systems include an active agent and a miscible polymer blend that includes a poly(ethylene-co-(meth)acrylate) and a second polymer not including poly(ethylene vinyl acetate).
Type:
Application
Filed:
August 13, 2003
Publication date:
March 11, 2004
Applicant:
Medtronic, Inc.
Inventors:
SuPing Lyu, Randall V. Sparer, Christopher M. Hobot, Kiem Dang
Abstract: A catheter assembly for treatment of cardiac arrhythmia. The catheter assembly includes a catheter body and an ablative energy source. The catheter body includes a proximal portion, an intermediate portion, and a distal portion. The intermediate portion extends from the proximal portion and defines a longitudinal axis. The distal portion extends from the intermediate portion and includes an ablation section and a tip. The ablation section forms a loop defining a diameter greater than an outer dimension of a pulmonary vein ostium. The tip extends distally from the ablation section and is configured to locate a pulmonary vein. Finally, the ablative energy source is associated with the ablation section. With this configuration, upon activation of the energy source, the ablation section ablates a desired lesion pattern. In one preferred embodiment, the ablation section forms a distally decreasing radius helix, whereas the tip includes a relatively linear leader section.
Abstract: Extremely hydrophobic nitric oxide (NO) releasing polymers are disclosed. The extremely hydrophobic NO-releasing polymers provided are extensively cross-linked polyamine-derivatized divinylbenzene diazeniumdiolates. These polymers can be loaded with extremely high NO levels and designed to release NO in manners than mimic natural biological systems. The NO-releasing extremely hydrophobic polymers provided can maintain a sustained NO release for periods exceeding nine months. Also provided are related medical devices made using these NO-releasing extremely hydrophobic polymers.
Type:
Grant
Filed:
October 4, 2001
Date of Patent:
March 9, 2004
Assignees:
Medtronic AVE Inc., United States of America
Inventors:
Anthony L. Fitzhugh, Robert Cafferata, Larry K. Keefer
Abstract: A bioprosthesis sealing film strip is attached to a surgical stapler by passing a jaw of the stapler through openings formed in the ends of the strip. Following stapling the strip is released by making a cut from the opening to the edge of the strip. Alternatively, one end of the strip may be releasably secured to pins formed on the jaw.
Abstract: An ESD protection circuit protects circuitry internal to an integrated circuit from ESD damage to electrostatic discharge voltages occurring at one or more of the inputs of the integrated circuit while maintaining substantially zero effective capacitance at the inputs. The ESD protection circuit includes a pair of diodes of opposite conductivity coupled between at least one of the inputs of the integrated circuit and an internal node thereof for providing current paths to the operating supply rails when ESD voltages occurring at the input forward bias the diodes. A unity gain amplifier provides feedback between the input and the internal circuit node to maintain a zero voltage difference therebetween whereby the effective capacitance seen at the input is reduced to substantially zero.
Abstract: Disclosed is an improved system and method to selectively promote tissue in-growth on, or adjacent to, an implantable medical device. In one embodiment, at least one surface of the housing of a medical device is in contact with a first portion of a porous PTFE having a pore size adapted to prevent substantially all tissue in-growth. This first portion, or layer, of porous PTFE material is further in contact at predetermined locations with an additional porous PTFE layer having a pore size adapted to selectively promote tissue in-growth only at the predetermined locations. Each of the PTFE layers may be formed of porous PTFE tubing or tape. Alternatively, the two layers may comprise a single composite structure that has a more porous material exposed on a first surface, and a less porous, more dense, material on a second surface. Another embodiment of the invention involves forming the layers of PTFE into a removable member that is adjacent to at least one surface of the implantable medical device.
Type:
Grant
Filed:
April 5, 2001
Date of Patent:
March 9, 2004
Assignee:
Medtronic, Inc.
Inventors:
Thomas M. Soukup, Stephen Sundquist, Roger Dahl, Gregory A. Boser